Eli Lilly: Among patients with platinum-sensitive ovarian cancer, the first phase clinical data achieved 79% confirmed objective remission rate and 100% disease control rate.

Zhitongcaijing · 2d ago
Eli Lilly: Among patients with platinum-sensitive ovarian cancer, the first phase clinical data achieved 79% confirmed objective remission rate and 100% disease control rate.